Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.77 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBLEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.222EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.470EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.31 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.51 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.323EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used